Literature DB >> 28675911

Patients' Knowledge about Prescribed Antipsychotics and Medication Adherence in Schizophrenia: A Cross-Sectional Survey.

Nobuhiro Nagai1, Hideaki Tani1, Takefumi Suzuki1,2, Saeko Ikai1, Philip Gerretsen3,4, Masaru Mimura1, Hiroyuki Uchida1,4.   

Abstract

Introduction Data on the knowledge about antipsychotic medications prescribed in patients with schizophrenia are very limited. Moreover, it remains unclear how patients' knowledge about prescribed antipsychotics affects medication adherence. Methods ighty-one Japanese outpatients with schizophrenia according to the International Classification of Diseases, 10th edition, were included. Patients' knowledge of the primary antipsychotics prescribed to them in terms of therapeutic effects, type, and implicated neurotransmitters was assessed with a multiple-choice questionnaire developed for this study. Medication possession ratios (MPRs) were compared between patients who answered correctly and those who did not in each category. Results The percentages of subjects who answered correctly regarding antipsychotic effects, type, and implicated neurotransmitters were low at 30.9%, 30.9%, and 7.4%, respectively. No differences were found in MPRs between subjects who answered correctly and those who did not. Discussion Our preliminary results indicate that patients lack knowledge about their antipsychotic medications. More concerning, they suggest that knowledge about prescribed antipsychotics may not directly translate into actual medication adherence in patients with schizophrenia. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28675911     DOI: 10.1055/s-0043-113828

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  5 in total

1.  What do patients learn about psychotropic medications on the web? A natural language processing study.

Authors:  Kamber L Hart; Roy H Perlis; Thomas H McCoy
Journal:  J Affect Disord       Date:  2019-09-10       Impact factor: 4.839

2.  Drug Attitude, Insight, and Patient's Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey.

Authors:  Nobuhiro Nagai; Hideaki Tani; Kazunari Yoshida; Philip Gerretsen; Takefumi Suzuki; Saeko Ikai-Tani; Masaru Mimura; Hiroyuki Uchida
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-23       Impact factor: 2.570

3.  Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective study.

Authors:  Dulcinea Vega; Francisco J Acosta; Pedro Saavedra
Journal:  World J Psychiatry       Date:  2020-11-19

4.  Enabling patients to cope with psychotropic medication in mental health care: Evaluation and reports of the new inventory MedSupport.

Authors:  Karin Drivenes; John-Kåre Vederhus; Vegard Øksendal Haaland; Torleif Ruud; Yina Luk Hauge; Hilde Regevik; Ragnhild Sørum Falk; Lars Tanum
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

5.  Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional study.

Authors:  Kie Takahashi; Ryoko Yamazawa; Takefumi Suzuki; Masaru Mimura; Hiroyuki Uchida
Journal:  Neuropsychopharmacol Rep       Date:  2020-06-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.